Plus   Neg

BAT Unit Acquires 19.9% Equity Investment In Organigram - Quick Facts

BAT Group has signed a strategic collaboration agreement with Organigram Inc., a subsidiary of Organigram Holdings. Organigram Inc. is a licensed producer of cannabis and cannabis-derived products in Canada.?A BAT subsidiary will acquire a 19.9% equity stake in Organigram Holdings to become the largest shareholder, with the ability to appoint two directors to Organigram Holdings' board. The investment, valued at approximately 126 million pounds, was priced at C$3.79 per share.

To operationalise the collaboration agreement, a "Centre of Excellence" will be established to focus on developing the next generation of cannabis products with an initial focus on cannabidiol. BAT and Organigram will contribute scientists, researchers, and product developers to the Centre of Excellence. BAT and Organigram will grant each other a licence to certain intellectual property to enable the development of new and potentially disruptive products.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Performance Food Group Co. announced Tuesday its agreement to acquire Core-Mark Holding Co., Inc., a wholesale distributor to the convenience retail industry, in around $2.5 billion stock and cash transaction, including net debt. In pre-markey activity on Nasdaq, Core-Mark shares were gaining around 9 percent to trade at $45.86. Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2022 that declined 31.6 percent from last year, hurt by net losses on equity investments, However, adjusted earnings per share and quarterly revenues topped analysts' expectations. The retailer also raised its guidance for the second quarter and for the full-year 2022. European Medicines Agency or EMA announced that Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech, can have more flexible storage conditions, including up to one month in a normal fridge. The proposed change in the approved storage conditions, recommended by EMA's human medicines committee or CHMP, will help in easy handling of the vaccine in vaccination centres across the EU.
Follow RTT